trecobox.com.br Traffic Analytics & Website Stats
trecobox.com.br is a domain having .com.br extension. trecobox.com.br is a arts and entertainment/humor website. trecobox.com.br gets 1,397,241 traffic per month, the site is estimated to be worth $684,164.00. Over the last three months, trecobox.com.br's global ranking has increased from 304,189 to 58,373. trecobox.com.br's traffic has increased by 280.29% compared to last month, which is already a sign. Which countries sent the most traffic to trecobox.com.br lately? Last month Brazil was the top country sending traffic to trecobox.com.br. trecobox.com.br's audience is 71.58% male and 28.42% female. The largest age group of visitors are 18 - 24 year olds.
- Traffic Report
-
Monthly Unique Visitors:
950,228
-
Monthly Pageviews:
1,397,241
- Estimated Valuation
-
Income Per Day:
$ 1,425
-
Estimated Worth:
$ 684,164
- Geography & Country Targeting
-
Countries Total Count:
18
-
Hot Country & Region:
Brazil
- Search keywords & Backlinks
-
Keywords Total Count:
2,952
-
Backlinks Sites:
4
- Global Ranks
-
Global Rank:
58,373
-
Country Rank:
10
- Global Rank Change
-
Global Rank Change:
+127,514
-
Country Rank Change:
+6,058
- Web Information
- HTTP Information
- Whois Information
Web Server Information
-
Hosted IP Address:
0.0.0.0
-
Hosted Country:
unknow
-
Location Latitude:
0
-
Location Longitude:
0
Page Title of trecobox.com.br
Trecobox - Cosplay, Filmes, Séries, HQs, Animes e Games
Meta Description of trecobox.com.br
Notícias sobre Cosplay, Filmes, Séries, HQs, Animes e Games. Isso e muito mais pode ser encontrado no site Trecobox.
Meta Tags of trecobox.com.br
Website Inpage Analysis
-
H1 Headings:
1
-
H2 Headings:
20
-
H3 Headings:
0
-
H4 Headings:
0
-
H5 Headings:
0
-
H6 Headings:
0
-
Total IFRAMEs:
0
-
Total Images:
3
-
Total Forms:
2
-
Total Scripts:
29
-
Google Adsense:
pub-9769021838213495
-
Google Analytics:
UA-91404611
HTTP Header Analysis
Strict-Transport-Security: max-age=63072000; includeSubDomains; preload
Content-Security-Policy: upgrade-insecure-requests
X-Xss-Protection: 0
X-Content-Type-Options: nosniff
Referrer-Policy: strict-origin-when-cross-origin
X-Frame-Options: SAMEORIGIN
Cross-Origin-Opener-Policy: same-origin-allow-popups
Cross-Origin-Resource-Policy: cross-origin
X-Dns-Prefetch-Control: on
Content-Type: text/html; charset=UTF-8
Link:
X-Litespeed-Cache-Control: public,max-age=604800
X-Litespeed-Tag: a07_HTTP.200,a07_PGSRP,a07_home,a07_URL.6666cd76f96956469e7be39d750cc7d9,a07_F,a07_guest,a07_,a07_MIN.7c875a0e97530e6868292542d95c8066.js
Vary: Accept-Encoding
ETag: "3389811-1667229682;gz"
X-Litespeed-Cache: miss
Content-Encoding: gzip
Date: Mon, 31 Oct 2022 15:21:22 GMT
Server: LiteSpeed
Alt-Svc: h3=":443"; ma=2592000, h3-29=":443"; ma=2592000, h3-Q050=":443"; ma=2592000, h3-Q046=":443"; ma=2592000, h3-Q043=":443"; ma=2592000, quic=":443"; ma=2592000; v="43,46"
Via: 1.1 google
Alt-Svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
Transfer-Encoding: chunked
Full WHOIS Lookup
Similarly Ranked Websites
-
Xem phim hay online cho điện thoại, máy tính, tivi AnimeViSub
animevi.net 46,564
-
find your favorite movie or tv show right now! find the latest and greatest to the classics. action kungfu movies, romantic chick flicks, thrillers that will have you on the edge of your seat, all for you to enjoy on your pc, mobile or tablet.
just-watch-it.com 145,749
-
Número 1 em séries no Brasil
mixdeseries.com.br 37,775
-
Browse and Watch all your favorite online movies & series for free!
cineinc.biz 164,673
-
Find your favorite Movie or TV show right now! Find the latest and greatest to the classics. Action Kungfu movies, Romantic chick flicks, Thrillers that will have you on the edge of your seat, all for you to enjoy on your PC, Mobile or tablet.
just-watch.club 128,207
-
Nikos Pekiaridis/NurPhoto via Getty Images(NEW YORK) -- Pfizer and BioNTech have launched a clinical trial on a vaccine targeting both COVID-19 and influenza, the companies announced Thursday. The phase 1 trial is being done in the United States with 180 participants between the ages of 18 and 64, with the first participant dosed this week, the companies said. The follow-up period for each participant will be six months. "By combining both indications in one vaccine approach, we aim to provide individuals with an efficient way to receive immunization against two severe respiratory diseases with evolving viruses that require vaccine adaptation," Dr. Ugur Sahin, CEO and co-founder of BioNTech, said in a statement. The combination vaccine is based on the currently available bivalent COVID-19 booster and a quadrivalent mRNA flu vaccine, which is designed to protect against four different flu viruses. The phase 1 trial will test for safety, immune response and optimal dose level of the combination vaccine, before moving on to larger trials. The data will also provide insight into the potential of mRNA vaccines to address more than one pathogen, Sahin said. Annaliesa Anderson, senior vice president and chief scientific officer of vaccine research and development for Pfizer, called this an "exciting step in our ongoing journey with BioNTech as we collectively look to transform the prevention of infectious diseases around the world." "Even with existing seasonal influenza vaccines, the burden of this virus is severe across the world causing thousands of deaths and hospitalizations every year," she said in a statement. Studies indicate COVID-19 vaccine efficacy fades over time, though it's not clear if every American will need an annual COVID-19 booster. As scientists continue to assess the need, several companies are at work on creating a single injection each fall that protects against both seasonal flu and COVID-19. In addition to Pfizer, pharmaceutical companies Moderna and Novavax have announced plans to work on a combo shot. Moderna said it anticipates starting clinical trials on a single-dose vaccine that combines a booster against COVID-19 and a booster against flu by the end of the year, with hopes of the vaccine being available for the 2023 season. "We believe this is a very large opportunity that is ahead of us, if we could bring to market a high efficacy pan-respiratory annual booster," Moderna COE Stéphane Bancel said during the Sept. 9 investor meeting. Last year, Novavax enrolled people in a Phase 1/2 study to evaluate the safety, tolerability and immune response of a combination vaccine using the company's seasonal influenza and COVID-19 vaccines. A phase 2 confirmation trial is expected to begin later this year, the company said in October. Copyright © 2022, ABC Audio. All rights reserved.
mycentraloregon.com 1,173,413
-
Notícias do mundo e do Brasil, lifestyle, celebridades, horóscopo, gastronomia, viagens e muito mais
sapobrasil.com.br 216,215
-
jmonline.com.br
jmonline.com.br 59,689
-
Tudo sobre os melhores serviços de streaming disponíveis no Brasil. Notícias oficiais sobre Netflix, Amazon Prime Video, HBO Max e Star+
streamingsbrasil.com 32,015
-
Teens through transformative experiences that cultivate belonging, skill-building, and connections to opportunities that grow leadership. As a non-profit education program focused on agriculture, we develop community in our process of developing young people.
teensgrowgreens.org 1,076,812